BPC 157 Banned: Key Facts on the Latest FDA Decision Is BPC 157 Banned? Oral vs. Injectable Forms Explained The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions BPC 157 Banned: Key Facts on the Latest FDA Decision The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York